uPAR expression in cerebral endothelial cells in CM patients is impaired, and the associated lesions have been suggested to contribute to an alteration of the blood–brain barrier and immunologic dysfunction in CM patients [21]. This evidence concerns the gene PLAUR and cutaneous mastocytosis.